Agenda - EHC - European Haemophilia Consortium

Agenda - EHC - European Haemophilia Consortium

European Haemophilia Consortium
European Haemophilia Consortium Round Table of Stakeholders
Von Willebrand Factor and Disease: Current
Clinical Issues
Monday, 16 June 2014, 12:30 to 16:30
Royal Windsor Hotel, Brussels
AGENDA
12.30 – 13.30
Registration followed by lunch outside of the meeting room
13.30 – 13.40
Welcome and introduction
Prof Paul Giangrande, Oxford University Hospitals, EHC MAG
13.40 – 13.55
Raising Awareness for VWD
Dr Antoine Rauch, Lille University Hospital
13.55 – 14.10
Living with VWD
Ms Baiba Ziemele, Latvian Haemophilia Society
14.10 – 14.25
Prophylaxis in VWD
Dr Susan Halimeh, Gerinnungszentrum Rhein-Ruhr
14.25 – 14.40
Combined FVIII/VWF versus RVWF
Prof Pier Mannuccio Mannucci, Hospital Cà Granda Foundation
14.40 – 15.10
Coffee Break
15.10 – 15.25
Role of VWF in preventing inhibitor development and
facilitating immune tolerance: Focus on Clinical Trials
Evidence
Dr Carmen Escuriola- Ettingshausen, Hämophilie-Zentrums Rhein
Main
15.25 – 15.40
Role of VWF in preventing inhibitor development and
facilitating immune tolerance: Focus on Immunology
Dr Srini V Kaveri, INSERM, Centre de Recherche des Cordeliers
15.40 – 15.55
Acquired VWD
Dr Augusto B Federici, University of Milan
15.55 – 16.30
Discussions and Conclusions
Prof Paul Giangrande, Oxford University Hospitals, EHC MAG
AISBL European Haemophilia Consortium (EHC) No. 887.106.966
Rue du Marché aux Herbes 105 b 14, 1000 Brussels, Belgium
Tel. +32-2-521 11 50; Fax. +32-2-520 68 66; Email: [email protected]; Website: www.ehc.eu
VAT: BE 0 887.106.966; Bank KBC - IBAN: BE80 7360 0157 2777 - BIC: KREDBEBB